Keyphrases
Older People
100%
Randomized Controlled Trial
74%
Older Patients
48%
Placebo
40%
Physical Function
39%
Vitamin D
35%
Sarcopenia
34%
Vitamin D Supplementation
34%
Quality of Life
26%
Meta-analysis
25%
Heart Failure Patients
24%
Confidence Interval
23%
Heart Failure
21%
Functional Impairment
21%
Physical Performance
21%
Blood Pressure
21%
Physical Activity
19%
Perindopril
18%
Systematic Meta-analysis
18%
Vascular Health
18%
6-minute Walk Distance (6MWD)
17%
Allopurinol
16%
25-hydroxyvitamin D Levels
16%
Muscle Mass
15%
Angiotensin-converting Enzyme Inhibitor (ACEi)
15%
Barthel Index
15%
Scotland
14%
Physical Activity Level
14%
Leucine
13%
Vascular Function
13%
Older Adults
13%
Cardiovascular Disease
13%
Risk Score
12%
Short Physical Performance Battery
12%
Treatment Effect
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Endothelial Function
11%
Between-group Difference
11%
Randomized Placebo-controlled Trial
11%
Patients with Heart Failure
11%
Inpatient Rehabilitation
10%
Exercise Training
10%
Hypertension
10%
Hospitalization
10%
Exercise Capacity
10%
Spironolactone
10%
Acute Kidney Injury
10%
Low Vitamin D
10%
B-type Natriuretic Peptide
10%
Vitamin D3
9%
Medicine and Dentistry
Randomized Controlled Trial
69%
Placebo
44%
Vitamin D
44%
Sarcopenia
29%
Congestive Heart Failure
28%
Supplementation
28%
Systematic Review
26%
Meta-Analysis
24%
Quality of Life
23%
Physical Performance
22%
Blood Pressure
20%
Perindopril
15%
Medicine
15%
Drug Therapy
14%
Exercise
13%
ACE Inhibitor
13%
Cardiovascular System
12%
Leucine
11%
Disease
11%
Apoplexy
11%
Chronic Kidney Disease
11%
Arm
11%
Treatment Effect
11%
25 Hydroxyvitamin D
10%
Sodium Bicarbonate
10%
Diabetes
9%
Muscle Function
8%
Brain Natriuretic Peptide
8%
Allopurinol
8%
Kidney Function
8%
Colecalciferol
8%
Spironolactone
7%
Cardiovascular Disease
7%
Primary Health Care
7%
Adverse Event
7%
Proportional Hazards Model
7%
Muscle Strength
6%
Endothelial Function
6%
Functional Disease
6%
Physical Activity
6%
Glycon
5%
Quality of Life Measure
5%
Walking Distance
5%
Orthostatic Hypotension
5%
Acidosis
5%
Clinical Trial
5%
Left Ventricular Hypertrophy
5%
Pulse Wave Velocity
5%
Hospital-Acquired Pneumonia
5%
Systolic Hypertension
5%
